NuOncology Labs, Inc. Share Price Other OTC
Equities
NLAB
US67057T1079
Construction & Engineering
Sales 2021 | - | Sales 2022 | - | Capitalization | 156M 12.32B |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net Debt 2022 | 41.88K 3.31M | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-2,229
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Yan-Ping Sheng
CEO | Chief Executive Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yan-Ping Sheng
CEO | Chief Executive Officer | 63 | - |
Sunny Sukardi
CHM | Chairman | 59 | 30/01/23 |
1st Jan change | Capi. | |
---|---|---|
+2.55% | 71.53B | |
-3.31% | 55.62B | |
+25.52% | 38.55B | |
+14.76% | 31.77B | |
+13.26% | 28.99B | |
+17.08% | 21.54B | |
+17.55% | 19.91B | |
+35.34% | 17.83B | |
+78.55% | 17.59B |